Evogene Ltd.
$2.00
24H
Market Cap
Volume
Supply
Price Chart
About Evogene Ltd. - EVGN.TA
Evogene Ltd. is an Israeli computational biology company that applies its proprietary technology to enhance product development for agriculture and pharmaceuticals, aiming to produce improved plants, microbes, and medicines. They leverage computational predictive biology to discover genes, small molecules, and microbial strains that can effectuate these enhancements.
What are Evogene Ltd.'s core values and mission statement?
Evogene Ltd. focuses on leveraging computational biology to improve product development in life sciences, guided by a commitment to innovation, sustainability, and partnerships to transform their research into real-world agricultural, industrial, and pharmaceutical applications. The company aims to harness advanced computational technologies to engineer key processes in plant and microbial biology.
Who founded Evogene Ltd. and when?
Evogene Ltd. was founded by a group of scientists including Martin Gerstel, Hagai Karchi, and Amir Barzilay, in 2002.
Who leads Evogene Ltd.?
As of the last update available, Ofer Haviv serves as the President and CEO of Evogene Ltd.
Where is Evogene Ltd. located, and what is its base country?
Evogene Ltd. is headquartered in Rehovot, Israel. Its base country is Israel.
On which exchanges is Evogene Ltd. traded?
Evogene Ltd. is traded on the Tel Aviv Stock Exchange (TASE) and on the NASDAQ under the ticker symbol EVGN.
Historical data
Evogene Ltd. (EVGN) Price Live Data
The live price of Evogene Ltd. (EVGN) is $2.00, with a trading volume of 3,167 in the last 24 hours. Wrapstocks updates the EVGN price in real-time. Evogene Ltd. is up 1.58% in the last 24 hours. The company has a live market cap of $111,953.84 and a supply of 55,966 EVGN stocks.
Evogene Ltd. (EVGN) is traded on Tel-Aviv Stock Exchange, and currently, the market is open; trading will be paused in 4 hours and 9 minutes.
